Jonathan McNeill

Jonathan McNeill

Chief Business OfficeratDyne Therapeutics· In the 2023 proxy

Pay in FY2023Dyne Therapeutics stock +14.8% the same year

Jonathan McNeill was paid $2.2M in FY2023 (Dec). Dyne Therapeutics stock rose 14.8% that year.

Pay$100 in the stock at the end of FY22 → $115
Pay is from the Summary Compensation Table of each Dyne Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Dyne TherapeuticsPublic company · 3 yr
    • Chief Business Officer2023 – Present · 3 yrStock in role +51%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?